Cizzle Biotechnology Holdings plc (LON:CIZ), the UK based diagnostics developer, has announced that it has signed a heads of terms to partner with CorePath Laboratories, a full service cancer reference laboratory, to
Cizzle Biotechnology plc (LON:CIZ), the UK based diagnostics developer, has announced that it has entered into a further research agreement with the University of York for the development of potential applications in cancer
Cizzle Biotechnology Holdings plc (LON:CIZ), the UK-based diagnostics developer, is pleased to report that St George Street Capital has provided an update on the further analysis of data from the ARCADIA
Cizzle Biotechnology’s Allan Syms discusses acquiring 5% economic interest of AZD 1656, what it is and what its looking to treat, more about St George Street Capital & Conduit Pharmaceuticals and how the agreement works from a financial point of view for the company in this exclusive interview with DirectorsTalk.
Cizzle Biotechnology Holdings plc (LON:CIZ) Executive Chairman Allan Syms joins DirectorsTalk Interviews to discuss an agreement with Conduit Pharmaceuticals and St George Street Capital to acquire a 5% economic interest in
Cizzle Biotechnology Holdings plc (LON:CIZ), the UK based diagnostics developer, is pleased to announce that it has entered into a definitive agreement with Conduit Pharmaceuticals Limited and St George Street Capital
Cizzle Biotechnology’s Allan Syms discusses the commercial and royalty agreement to develop and market their early lung cancer detection tests in China in this exclusive interview with DirectorsTalk.
Cizzle Biotechnology plc (LON:CIZ), focused on cancer diagnostics, was spun out of the University of York to exploit the biomarker, variant CIZ1b, for early detection of different forms of lung
Cizzle Biotechnology Holdings plc (LON:CIZ) Executive Chairman Allan Syms joins DirectorsTalk Interviews to discuss a full commercial development and royalty agreement to develop and market Cizzle Biotechnologies early lung cancer diagnostic
Cizzle Biotechnology plc (LON:CIZ), the UK based diagnostics developer, has announced that following the signing of a Memorandum of Understanding with the International Co-Innovation Centre for Advanced Medical Technology and Shenzhen
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
